Down & Dirty 30: Psoriatic Arthritis

Moderator(s)

• EW

  Elizabeth Wellsandt, PhD, DPT

  Professor (Assistant)
  University of Nebraska Medical Center

Speaker(s)

• DS

  Daniella Schwartz, MD

  National Institutes of Health Clinical Center

Psoriatic arthritis (PsA) is unique inflammatory arthritis that affects up to 20 percent of patients with psoriasis. Although it has the potential to cause severe joint destruction, it is often underdiagnosed and undertreated, particularly because PsA is less responsive to FDA-approved therapies than psoriatic skin disease. Additionally, psoriasis is associated with a number of other extracutaneous features that can increase morbidity and mortality in PsA patients. This session will briefly review the various presentations of PsA in patients with different types of psoriatic skin disease. Faculty presentations will be followed by a discussion of treatment options for patients with PsA, as well as screening requirements for associated comorbidities.

Learning Objectives:

• Identify the different presenting patterns and features of psoriatic arthritis
• Review treatment options and efficacy for patients with psoriatic arthritis
• Review the extra-articular comorbidities of patients with psoriatic arthritis, and associated screening guidelines

Presentations:

• 3:45 PM – 4:05 PM ET

  Down & Dirty 30: Psoriatic Arthritis
  Daniella Schwartz, MD – National Institutes of Health Clinical Center
• 4:05 PM – 4:15 PM ET

  Q&A